• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CT medium circulates in blood pool

Article

Photogen Technologies is testing a contrast agent that stays in the vascular system for at least 20 minutes with little diffusion outside. If tests pan out, the experimental agent, which has been tested only in animals, could serve as both a perfusion

Photogen Technologies is testing a contrast agent that stays in the vascular system for at least 20 minutes with little diffusion outside. If tests pan out, the experimental agent, which has been tested only in animals, could serve as both a perfusion and blood pool agent. Preclinical studies indicate that the proprietary agent, called PH-50, has potential in coronary, cardiac, great vessel, and renal arterial CT. Through luminaries at Stanford University, the New Hope, PA, company also hopes to explore the use of this agent as a means for imaging soft noncalcified plaques in coronary arteries, where its presence is a marker of likelihood to rupture and cause sudden death.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.